Overview
Kousseff syndrome is an extremely rare congenital disorder characterized by the combination of sacral meningocele (a type of neural tube defect affecting the lower spine) and conotruncal heart defects (malformations involving the outflow tracts of the heart, such as tetralogy of Fallot, truncus arteriosus, or transposition of the great arteries). The condition was first described by Boris Kousseff in 1984. Affected individuals present at birth with features that overlap significantly with those seen in velocardiofacial syndrome (22q11.2 deletion syndrome), including facial dysmorphism and cardiac anomalies, but the presence of a sacral neural tube defect is a distinguishing feature. The key body systems affected include the cardiovascular system (conotruncal cardiac malformations), the central nervous system and spine (sacral meningocele or other caudal neural tube defects), and craniofacial structures. Facial features may include a broad nasal bridge, micrognathia, and other dysmorphic characteristics. Some patients may also exhibit developmental delay, genitourinary anomalies, and other midline defects. The relationship between Kousseff syndrome and 22q11.2 deletion syndrome has been debated in the literature, with some authors suggesting that Kousseff syndrome may represent a variant within the spectrum of 22q11.2-related disorders, while others consider it a distinct entity. Treatment is symptomatic and supportive, focusing on surgical correction of cardiac defects and management of the neural tube defect. Neurosurgical intervention may be required for the sacral meningocele, and cardiac surgery is typically necessary to address the conotruncal heart malformations. Long-term follow-up with a multidisciplinary team including cardiology, neurosurgery, genetics, and developmental pediatrics is recommended. There is no cure for the underlying condition, and prognosis depends largely on the severity of the cardiac and neurological involvement.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Kousseff syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Kousseff syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Kousseff syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Kousseff syndrome.
Community
No community posts yet. Be the first to share your experience with Kousseff syndrome.
Start the conversation →Latest news about Kousseff syndrome
No recent news articles for Kousseff syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Kousseff syndrome
What is Kousseff syndrome?
Kousseff syndrome is an extremely rare congenital disorder characterized by the combination of sacral meningocele (a type of neural tube defect affecting the lower spine) and conotruncal heart defects (malformations involving the outflow tracts of the heart, such as tetralogy of Fallot, truncus arteriosus, or transposition of the great arteries). The condition was first described by Boris Kousseff in 1984. Affected individuals present at birth with features that overlap significantly with those seen in velocardiofacial syndrome (22q11.2 deletion syndrome), including facial dysmorphism and card
At what age does Kousseff syndrome typically begin?
Typical onset of Kousseff syndrome is neonatal. Age of onset can vary across affected individuals.